Revenue for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current revenue (TTM) is $29.44B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$29.44B
YoY change
+2.4%
5Y CAGR
+3.6%
Peak year (2015)
$32.64B
Cumulative revenue
$385.65B
Revenue history chart for Gilead Sciences (GILD) from 1990 to 2025
Revenue history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $29.44B | +2.4% | ||
| 2024 | $28.75B | +6.0% | ||
| 2023 | $27.12B | -0.6% | ||
| 2022 | $27.28B | -0.1% | ||
| 2021 | $27.30B | +10.6% | ||
| 2020 | $24.69B | +10.0% | ||
| 2019 | $22.45B | +1.5% | ||
| 2018 | $22.13B | -15.2% | ||
| 2017 | $26.11B | -14.1% | ||
| 2016 | $30.39B | -6.9% | ||
| 2015 | $32.64B | +31.1% | ||
| 2014 | $24.89B | +122.2% | ||
| 2013 | $11.20B | +15.5% | ||
| 2012 | $9.70B | +15.7% | ||
| 2011 | $8.39B | +5.5% | ||
| 2010 | $7.95B | +13.4% | ||
| 2009 | $7.01B | +31.4% | ||
| 2008 | $5.34B | +26.1% | ||
| 2007 | $4.23B | +39.8% | ||
| 2006 | $3.03B | +49.2% | ||
| 2005 | $2.03B | +53.1% | ||
| 2004 | $1.32B | +52.6% | ||
| 2003 | $867.86M | +85.9% | ||
| 2002 | $466.79M | +99.7% | ||
| 2001 | $233.77M | +19.5% | ||
| 2000 | $195.56M | +15.7% | ||
| 1999 | $169.00M | +11.8% | ||
| 1998 | $151.10M | +14.2% | ||
| 1997 | $132.30M | +296.1% | ||
| 1996 | $33.40M | +1137.0% | ||
| 1995 | $2.70M | -44.9% | ||
| 1994 | $4.90M | — | ||
| 1992 | $4.20M | +50.0% | ||
| 1991 | $2.80M | +115.4% | ||
| 1990 | $1.30M | — |
Revenue values are taken from Gilead Sciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual revenue for Gilead Sciences (GILD) came in at $29.44B – edged up 2.4% year-over-year.
Over 2020–2025 (5 years), Gilead Sciences revenue expanded at a +3.6% compound annual rate, sustaining 2 straight years of year-over-year growth.
Gilead Sciences revenue declined from $32.64B in 2015 to $29.44B in 2025, a 9.8% drawdown.
$32.64B stands as the all-time-high annual revenue, posted in 2015, against a low of $1.30M during 1990.
Within Healthcare, Gilead Sciences (GILD) ranks 9th among 8 peers we track. The peer median for revenue is $65.09B.
Gilead Sciences Revenue by Year
Gilead Sciences Revenue 2025: $29.44B
Gilead Sciences revenue in 2025 was $29.44B, edged up 2.4% from 2024.
Gilead Sciences Revenue 2024: $28.75B
Gilead Sciences revenue in 2024 was $28.75B, grew 6.0% from 2023.
Gilead Sciences Revenue 2023: $27.12B
Gilead Sciences revenue in 2023 was $27.12B, edged down 0.6% below 2022.
Gilead Sciences Revenue 2022: $27.28B
Gilead Sciences revenue in 2022 was $27.28B, edged down 0.1% below 2021.
Gilead Sciences Revenue 2021: $27.30B
Gilead Sciences revenue in 2021 was $27.30B.
See more financial history for Gilead Sciences (GILD).
Sector peers — Revenue
Companies in the same sector as Gilead Sciences, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Gilead Sciences's revenue?
- Latest reported revenue for Gilead Sciences (GILD) is $29.44B (period ending December 31, 2025).
How has Gilead Sciences revenue changed year-over-year?
- Gilead Sciences (GILD) revenue changed +2.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences revenue?
- Gilead Sciences (GILD) revenue compound annual growth rate is +3.6% over the most recent 5 years available.
When did Gilead Sciences revenue hit its highest annual value?
- Gilead Sciences revenue reached its highest annual value of $32.64B in 2015.
What was Gilead Sciences revenue in 2024?
- Gilead Sciences (GILD) revenue in 2024 was $28.75B.
What was Gilead Sciences revenue in 2025?
- Gilead Sciences (GILD) revenue in 2025 was $29.44B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.